000813 Share Price Performance
CN¥2.99
-0.23 (-7.14%)
Price CN¥2.99
Share Pricen/a
Dezhan Healthcare Company Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
000813 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Dezhan Healthcare Company Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -0.17
- 49.61%
- -90.30%
- 2.7%
About 000813
- Founded
- 1980
- Employees
- 1067
- CEO
- WebsiteView website
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, and hydroxyurea tablets and colchicine tablet. It also involved in the provision of biological peptides, industrial hemp, and medical service business. The company was founded in 1980 and is based in Beijing, the People’s Republic of China.
